Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinxieping is a traditional Chinese herbal medicine formulation used primarily for the treatment of psoriasis vulgaris. It is available in both tablet and granule forms. Clinical studies suggest that Yinxieping may exert its therapeutic effects by modulating immune responses—specifically, it has been shown to upregulate peroxisome proliferator-activated receptor gamma (PPARγ) expression in lesion tissue and decrease serum levels of pro-inflammatory cytokines interleukin-17 (IL-17) and interleukin-23 (IL-23), which are implicated in the pathogenesis of psoriasis[1][2][3]. The precise herbal composition is not detailed in the available sources, but it falls under the category of systemic Chinese herbal medicines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinxieping.